A TV story announcing a new trial of SYMBYX's PDCare Laser by Flinders University played on January 11 and 12 across Channel 7's Evening News as well as the Sunrise Morning Breakfast Program. This 6 month trial, based in Adelaide, South Australia, will include 36 participants divided into 3 groups. Some will use the equipment only, others will combine it with exercise, and the third group will be given fake equipment to monitor for placebo effects.
Application of light therapy on the gut and back of neck was again shown to be an effective treatment for a number of clinical signs of Parkinson’s, with some improvements being maintained for 45 weeks.
SYMBYX is delighted to announce today a new Parkinson’s randomised control clinical trial (RCT) in collaboration with The Hospital Research Foundation Group - Parkinson’s (THRFG) and Flinders University, Adelaide, Australia. THRFG - Parkinson’s is led by Olivia Nassaris (pictured above left). Principal investigator of the trial will be Dr Joyce Ramos, pictured (above right), of Flinders University, Adelaide. Joyce is attached to the College of Nursing and Health Sciences and is also a Research Fellow at the University of Queensland.
Australian medical technology company SYMBYX has completed its first human trial of the use of laser light therapy (photobiomodulation or PBM) to reduce the symptoms of Parkinson’s by targeting the gut-brain axis. The proof-of-concept trial showed that measures of mobility, cognition, dynamic balance, sleep, motivation, and fine motor skills of participants were all significantly improved.
It’s increasingly clear that chronic pain is often “neuroplastic” — generated by the brain in a misbegotten effort to protect us from danger....
The latest evidence comes in a peer-reviewed study just published study in the journal JAMA Psychiatry that includes striking results from a randomized controlled trial conducted at the University of Colorado at Boulder. In the study, 151 subjects with persistent back pain were randomly assigned to one of three groups.
Our very own SYMBYX Scientist, Dr Ann Liebert, presented the results of the recent ground-breaking Parkinson's trial in Adelaide (which used the PDCare Laser by SYMBYX) at last week's Photobiomodulation 2021 Conference held jointly by WALT (the World Association for Photobiomodulation Therapy) and NAALT (the North American Association for Photobiomodulation Therapy).
Often associated with breast cancer and/or removal of the lymph nodes, Lymphedema affects many people worldwide and starts with tingling, numbness, tightness and decreased flexibility in hands, arms, around the breast area or underarms.
